Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 09 2022
23 09 2022
Historique:
received:
29
06
2022
accepted:
05
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
epublish
Résumé
The heterogeneity in the pathological and clinical manifestations of ovarian cancer is a major hurdle impeding early and accurate diagnosis. A host of imaging modalities, including Doppler ultrasound, MRI, and CT, have been investigated to improve the assessment of ovarian lesions. We hypothesized that pathologic conditions might affect the ovarian vasculature and that these changes might be detectable by optical-resolution photoacoustic microscopy (OR-PAM). In our previous work, we developed a benchtop OR-PAM and demonstrated it on a limited set of ovarian and fallopian tube specimens. In this study, we collected data from over 50 patients, supporting a more robust statistical analysis. We then developed an efficient custom analysis pipeline for characterizing the vascular features of the samples, including the mean vessel diameter, vascular density, global vascular directionality, local vascular definition, and local vascular tortuosity/branchedness. Phantom studies using carbon fibers showed that our algorithm was accurate within an acceptable error range. Between normal ovaries and normal fallopian tubes, we observed significant differences in five of six extracted vascular features. Further, we showed that distinct subsets of vascular features could distinguish normal ovaries from cystic, fibrous, and malignant ovarian lesions. In addition, a statistically significant difference was found in the mean vascular tortuosity/branchedness values of normal and abnormal tubes. The findings support the proposition that OR-PAM can help distinguish the severity of tubal and ovarian pathologies.
Identifiants
pubmed: 36151126
doi: 10.1038/s41598-022-19778-1
pii: 10.1038/s41598-022-19778-1
pmc: PMC9508221
doi:
Substances chimiques
Carbon Fiber
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
15850Subventions
Organisme : NCI NIH HHS
ID : R01 CA237664
Pays : United States
Organisme : NCI NIH HHS
ID : R01CA237664
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
IEEE Trans Biomed Eng. 2016 May;63(5):1082-6
pubmed: 26394410
Radiology. 1998 Jul;208(1):103-10
pubmed: 9646799
Gynecol Oncol. 2012 Jan;124(1):164-9
pubmed: 22032835
CA Cancer J Clin. 2018 Jul;68(4):284-296
pubmed: 29809280
Sci Rep. 2019 Oct 4;9(1):14306
pubmed: 31586106
Am J Pathol. 2016 Apr;186(4):733-47
pubmed: 27012190
Cancer Cell. 2013 Dec 9;24(6):751-65
pubmed: 24332043
Diagn Interv Imaging. 2020 Mar;101(3):147-155
pubmed: 31987805
J Coll Physicians Surg Pak. 2021 Sep;31(9):1057-1063
pubmed: 34500521
Cancer. 1997 Sep 1;80(5):899-907
pubmed: 9307190
Pathobiology. 2018;85(1-2):41-49
pubmed: 29020678
Cancer Causes Control. 2020 Jan;31(1):25-31
pubmed: 31673820
Lancet Oncol. 2009 Apr;10(4):327-40
pubmed: 19282241
J Clin Oncol. 2005 Aug 20;23(24):5588-96
pubmed: 16110018
Acad Radiol. 2005 Oct;12(10):1232-40
pubmed: 16179200
Physiol Rev. 2011 Jul;91(3):1071-121
pubmed: 21742796
Radiology. 2008 Jul;248(1):148-59
pubmed: 18458244
Ultrasound Obstet Gynecol. 2018 Mar;51(3):293-303
pubmed: 28639753
Hum Pathol. 2011 Jul;42(7):918-31
pubmed: 21683865
Gynecol Oncol. 2006 Jul;102(1):41-8
pubmed: 16386783
J Biomed Opt. 2012 May;17(5):056016
pubmed: 22612139
Stroke. 2016 Oct;47(10):2548-52
pubmed: 27531344
Clin Transl Oncol. 2009 Sep;11(9):564-71
pubmed: 19775995
Curr Med Sci. 2020 Feb;40(1):184-191
pubmed: 32166682
CA Cancer J Clin. 2020 Nov;70(6):443-459
pubmed: 32940362
J Biomed Opt. 2010 Jan-Feb;15(1):011101
pubmed: 20210427
Gynecol Oncol. 2015 Aug;138(2):223-6
pubmed: 26166806
AJR Am J Roentgenol. 2020 Mar;214(3):694-700
pubmed: 31770022